nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—RPS6KB1—coronary artery disease	0.111	0.36	CbGaD
Sunitinib—RPS6KA3—Acetylsalicylic acid—coronary artery disease	0.0965	0.303	CbGbCtD
Sunitinib—JAK2—coronary artery disease	0.0923	0.298	CbGaD
Sunitinib—KDR—coronary artery disease	0.0544	0.176	CbGaD
Sunitinib—KIT—coronary artery disease	0.0513	0.166	CbGaD
Sunitinib—ABCC2—Olmesartan—coronary artery disease	0.0101	0.0318	CbGbCtD
Sunitinib—ABCC4—Rosuvastatin—coronary artery disease	0.01	0.0315	CbGbCtD
Sunitinib—ABCC4—Atorvastatin—coronary artery disease	0.00831	0.0261	CbGbCtD
Sunitinib—ABCC2—Pitavastatin—coronary artery disease	0.0081	0.0254	CbGbCtD
Sunitinib—ABCC2—Telmisartan—coronary artery disease	0.0081	0.0254	CbGbCtD
Sunitinib—ABCG2—Pitavastatin—coronary artery disease	0.00732	0.023	CbGbCtD
Sunitinib—ABCG2—Telmisartan—coronary artery disease	0.00732	0.023	CbGbCtD
Sunitinib—ABCC2—Ezetimibe—coronary artery disease	0.00597	0.0187	CbGbCtD
Sunitinib—CYP3A7—Eplerenone—coronary artery disease	0.00575	0.018	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.00575	0.018	CbGbCtD
Sunitinib—ABCC2—Simvastatin—coronary artery disease	0.00555	0.0174	CbGbCtD
Sunitinib—ABCC2—Pravastatin—coronary artery disease	0.00543	0.017	CbGbCtD
Sunitinib—ABCC2—Lovastatin—coronary artery disease	0.00543	0.017	CbGbCtD
Sunitinib—ABCG2—Rosuvastatin—coronary artery disease	0.0054	0.0169	CbGbCtD
Sunitinib—ABCG2—Ezetimibe—coronary artery disease	0.0054	0.0169	CbGbCtD
Sunitinib—ABCC2—Atorvastatin—coronary artery disease	0.00495	0.0155	CbGbCtD
Sunitinib—ABCG2—Pravastatin—coronary artery disease	0.00491	0.0154	CbGbCtD
Sunitinib—ABCB1—Ticagrelor—coronary artery disease	0.00489	0.0153	CbGbCtD
Sunitinib—CYP3A5—Clopidogrel—coronary artery disease	0.00464	0.0146	CbGbCtD
Sunitinib—ABCC2—Furosemide—coronary artery disease	0.00462	0.0145	CbGbCtD
Sunitinib—CYP3A5—Eplerenone—coronary artery disease	0.00431	0.0135	CbGbCtD
Sunitinib—CYP3A7—Simvastatin—coronary artery disease	0.00371	0.0116	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00371	0.0116	CbGbCtD
Sunitinib—CYP3A7—Lovastatin—coronary artery disease	0.00363	0.0114	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00363	0.0114	CbGbCtD
Sunitinib—CYP3A7—Atorvastatin—coronary artery disease	0.0033	0.0104	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0033	0.0104	CbGbCtD
Sunitinib—ABCB1—Perindopril—coronary artery disease	0.00302	0.00947	CbGbCtD
Sunitinib—ABCB1—Clopidogrel—coronary artery disease	0.00302	0.00947	CbGbCtD
Sunitinib—CYP3A5—Rosuvastatin—coronary artery disease	0.00299	0.00938	CbGbCtD
Sunitinib—CYP3A4—Ticagrelor—coronary artery disease	0.00293	0.00919	CbGbCtD
Sunitinib—CYP3A5—Simvastatin—coronary artery disease	0.00278	0.00872	CbGbCtD
Sunitinib—CYP3A5—Pravastatin—coronary artery disease	0.00272	0.00853	CbGbCtD
Sunitinib—CYP3A5—Lovastatin—coronary artery disease	0.00272	0.00853	CbGbCtD
Sunitinib—ABCB1—Telmisartan—coronary artery disease	0.00264	0.00828	CbGbCtD
Sunitinib—ABCB1—Pitavastatin—coronary artery disease	0.00264	0.00828	CbGbCtD
Sunitinib—CYP3A4—Fenofibrate—coronary artery disease	0.00261	0.00819	CbGbCtD
Sunitinib—ABCB1—Enalapril—coronary artery disease	0.0025	0.00785	CbGbCtD
Sunitinib—ABCB1—Lisinopril—coronary artery disease	0.0025	0.00785	CbGbCtD
Sunitinib—CYP3A5—Atorvastatin—coronary artery disease	0.00248	0.00777	CbGbCtD
Sunitinib—CYP3A5—Losartan—coronary artery disease	0.00227	0.00711	CbGbCtD
Sunitinib—ABCB1—Timolol—coronary artery disease	0.00213	0.00668	CbGbCtD
Sunitinib—CYP3A4—Gemfibrozil—coronary artery disease	0.00209	0.00655	CbGbCtD
Sunitinib—ABCB1—Ezetimibe—coronary artery disease	0.00195	0.00611	CbGbCtD
Sunitinib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0019	0.00595	CbGbCtD
Sunitinib—ABCB1—Captopril—coronary artery disease	0.00187	0.00588	CbGbCtD
Sunitinib—CYP3A4—Clopidogrel—coronary artery disease	0.00181	0.00568	CbGbCtD
Sunitinib—ABCB1—Simvastatin—coronary artery disease	0.00181	0.00568	CbGbCtD
Sunitinib—ABCB1—Pravastatin—coronary artery disease	0.00177	0.00555	CbGbCtD
Sunitinib—ABCB1—Lovastatin—coronary artery disease	0.00177	0.00555	CbGbCtD
Sunitinib—CYP3A4—Eplerenone—coronary artery disease	0.00168	0.00528	CbGbCtD
Sunitinib—ABCB1—Atorvastatin—coronary artery disease	0.00161	0.00506	CbGbCtD
Sunitinib—CYP3A4—Enalapril—coronary artery disease	0.0015	0.0047	CbGbCtD
Sunitinib—ABCB1—Losartan—coronary artery disease	0.00147	0.00463	CbGbCtD
Sunitinib—Metoclopramide—CYP11B2—coronary artery disease	0.0013	0.761	CrCbGaD
Sunitinib—CYP3A4—Rosuvastatin—coronary artery disease	0.00117	0.00366	CbGbCtD
Sunitinib—CYP3A4—Ezetimibe—coronary artery disease	0.00117	0.00366	CbGbCtD
Sunitinib—CYP3A4—Simvastatin—coronary artery disease	0.00108	0.0034	CbGbCtD
Sunitinib—CYP3A4—Pravastatin—coronary artery disease	0.00106	0.00333	CbGbCtD
Sunitinib—CYP3A4—Lovastatin—coronary artery disease	0.00106	0.00333	CbGbCtD
Sunitinib—CYP3A4—Atorvastatin—coronary artery disease	0.000966	0.00303	CbGbCtD
Sunitinib—CYP3A4—Losartan—coronary artery disease	0.000883	0.00277	CbGbCtD
Sunitinib—Procainamide—SLC22A3—coronary artery disease	0.000409	0.239	CrCbGaD
Sunitinib—PRPF4—Levobunolol—Timolol—coronary artery disease	0.000261	0.108	CbGdCrCtD
Sunitinib—PRPF4—Levobunolol—Penbutolol—coronary artery disease	0.000222	0.0916	CbGdCrCtD
Sunitinib—TLK2—Progesterone—Eplerenone—coronary artery disease	0.000198	0.0818	CbGdCrCtD
Sunitinib—PRPF4—Pimozide—Ezetimibe—coronary artery disease	0.000195	0.0806	CbGdCrCtD
Sunitinib—PRPF4—Lovastatin—Simvastatin—coronary artery disease	0.000193	0.0799	CbGdCrCtD
Sunitinib—PRPF4—Lovastatin—Pravastatin—coronary artery disease	0.000193	0.0799	CbGdCrCtD
Sunitinib—DAPK1—blood—coronary artery disease	0.000187	0.00234	CbGeAlD
Sunitinib—STK16—heart—coronary artery disease	0.000187	0.00234	CbGeAlD
Sunitinib—STK38—cardiac atrium—coronary artery disease	0.000186	0.00233	CbGeAlD
Sunitinib—RPS6KA2—cardiac atrium—coronary artery disease	0.000186	0.00233	CbGeAlD
Sunitinib—IRAK1—myocardium—coronary artery disease	0.000186	0.00233	CbGeAlD
Sunitinib—PRPF4—Fluvastatin—Pitavastatin—coronary artery disease	0.000186	0.0768	CbGdCrCtD
Sunitinib—HIPK2—heart—coronary artery disease	0.000186	0.00233	CbGeAlD
Sunitinib—HIPK3—heart—coronary artery disease	0.000186	0.00233	CbGeAlD
Sunitinib—SLK—cardiac ventricle—coronary artery disease	0.000185	0.00232	CbGeAlD
Sunitinib—RIOK2—heart—coronary artery disease	0.000184	0.0023	CbGeAlD
Sunitinib—TNK1—heart—coronary artery disease	0.000184	0.0023	CbGeAlD
Sunitinib—CSNK1G2—cardiac atrium—coronary artery disease	0.000184	0.0023	CbGeAlD
Sunitinib—PKN1—cardiac atrium—coronary artery disease	0.000184	0.0023	CbGeAlD
Sunitinib—RPS6KB1—myocardium—coronary artery disease	0.000183	0.00229	CbGeAlD
Sunitinib—JAK2—cardiac ventricle—coronary artery disease	0.000182	0.00228	CbGeAlD
Sunitinib—MAP4K1—heart—coronary artery disease	0.000182	0.00228	CbGeAlD
Sunitinib—BRD4—blood—coronary artery disease	0.000181	0.00227	CbGeAlD
Sunitinib—STK11—blood—coronary artery disease	0.000181	0.00227	CbGeAlD
Sunitinib—PRPF4—cardiac atrium—coronary artery disease	0.000181	0.00226	CbGeAlD
Sunitinib—AXL—myocardium—coronary artery disease	0.000181	0.00226	CbGeAlD
Sunitinib—FYN—cardiac ventricle—coronary artery disease	0.00018	0.00225	CbGeAlD
Sunitinib—RIOK1—blood—coronary artery disease	0.000179	0.00224	CbGeAlD
Sunitinib—RPS6KA1—blood—coronary artery disease	0.000179	0.00224	CbGeAlD
Sunitinib—DAPK3—heart—coronary artery disease	0.000179	0.00224	CbGeAlD
Sunitinib—PRPF4B—cardiac atrium—coronary artery disease	0.000178	0.00223	CbGeAlD
Sunitinib—CLK2—heart—coronary artery disease	0.000177	0.00221	CbGeAlD
Sunitinib—MAP4K2—heart—coronary artery disease	0.000176	0.0022	CbGeAlD
Sunitinib—STK39—cardiac atrium—coronary artery disease	0.000176	0.0022	CbGeAlD
Sunitinib—MARK2—blood—coronary artery disease	0.000176	0.0022	CbGeAlD
Sunitinib—TNIK—blood—coronary artery disease	0.000176	0.0022	CbGeAlD
Sunitinib—MAP3K3—cardiac ventricle—coronary artery disease	0.000176	0.0022	CbGeAlD
Sunitinib—HIPK2—cardiovascular system—coronary artery disease	0.000175	0.0022	CbGeAlD
Sunitinib—HIPK3—cardiovascular system—coronary artery disease	0.000175	0.0022	CbGeAlD
Sunitinib—SGK3—blood—coronary artery disease	0.000174	0.00218	CbGeAlD
Sunitinib—SLK—myocardium—coronary artery disease	0.000174	0.00218	CbGeAlD
Sunitinib—STK3—heart—coronary artery disease	0.000174	0.00217	CbGeAlD
Sunitinib—CSNK2A1—cardiac atrium—coronary artery disease	0.000174	0.00217	CbGeAlD
Sunitinib—ICK—blood—coronary artery disease	0.000173	0.00216	CbGeAlD
Sunitinib—JAK2—myocardium—coronary artery disease	0.000172	0.00215	CbGeAlD
Sunitinib—ROCK1—heart—coronary artery disease	0.000171	0.00215	CbGeAlD
Sunitinib—MYLK—cardiac atrium—coronary artery disease	0.000171	0.00214	CbGeAlD
Sunitinib—FLT1—cardiac ventricle—coronary artery disease	0.00017	0.00213	CbGeAlD
Sunitinib—FYN—myocardium—coronary artery disease	0.000169	0.00212	CbGeAlD
Sunitinib—DAPK3—cardiovascular system—coronary artery disease	0.000168	0.00211	CbGeAlD
Sunitinib—DYRK1A—heart—coronary artery disease	0.000167	0.00209	CbGeAlD
Sunitinib—NUAK1—blood—coronary artery disease	0.000167	0.00209	CbGeAlD
Sunitinib—CHEK2—blood—coronary artery disease	0.000167	0.00209	CbGeAlD
Sunitinib—PRPF4—Fluvastatin—Rosuvastatin—coronary artery disease	0.000166	0.0684	CbGdCrCtD
Sunitinib—MAP3K3—myocardium—coronary artery disease	0.000165	0.00207	CbGeAlD
Sunitinib—OXSR1—blood—coronary artery disease	0.000165	0.00207	CbGeAlD
Sunitinib—SNRK—blood—coronary artery disease	0.000165	0.00207	CbGeAlD
Sunitinib—MERTK—heart—coronary artery disease	0.000163	0.00204	CbGeAlD
Sunitinib—RPS6KA2—blood—coronary artery disease	0.000163	0.00204	CbGeAlD
Sunitinib—STK38—blood—coronary artery disease	0.000163	0.00204	CbGeAlD
Sunitinib—DAPK2—cardiac atrium—coronary artery disease	0.000162	0.00203	CbGeAlD
Sunitinib—YES1—cardiac ventricle—coronary artery disease	0.000162	0.00203	CbGeAlD
Sunitinib—ROCK1—cardiovascular system—coronary artery disease	0.000162	0.00202	CbGeAlD
Sunitinib—MAP4K4—heart—coronary artery disease	0.00016	0.00201	CbGeAlD
Sunitinib—TAOK3—cardiac ventricle—coronary artery disease	0.00016	0.00201	CbGeAlD
Sunitinib—PKN1—blood—coronary artery disease	0.00016	0.00201	CbGeAlD
Sunitinib—CSNK1G2—blood—coronary artery disease	0.00016	0.00201	CbGeAlD
Sunitinib—FLT1—myocardium—coronary artery disease	0.00016	0.002	CbGeAlD
Sunitinib—HIPK3—cardiac atrium—coronary artery disease	0.000159	0.00199	CbGeAlD
Sunitinib—PRPF4—Simvastatin—Pravastatin—coronary artery disease	0.000158	0.0654	CbGdCrCtD
Sunitinib—PRPF4—Simvastatin—Lovastatin—coronary artery disease	0.000158	0.0654	CbGdCrCtD
Sunitinib—FLT3—heart—coronary artery disease	0.000158	0.00198	CbGeAlD
Sunitinib—MAP3K12—heart—coronary artery disease	0.000158	0.00198	CbGeAlD
Sunitinib—PRPF4—blood—coronary artery disease	0.000158	0.00198	CbGeAlD
Sunitinib—DYRK1A—cardiovascular system—coronary artery disease	0.000158	0.00197	CbGeAlD
Sunitinib—RIOK2—cardiac atrium—coronary artery disease	0.000157	0.00197	CbGeAlD
Sunitinib—RPS6KA3—heart—coronary artery disease	0.000156	0.00195	CbGeAlD
Sunitinib—PRPF4B—blood—coronary artery disease	0.000156	0.00195	CbGeAlD
Sunitinib—MAP2K1—heart—coronary artery disease	0.000155	0.00194	CbGeAlD
Sunitinib—STK39—blood—coronary artery disease	0.000153	0.00192	CbGeAlD
Sunitinib—CSNK1A1—heart—coronary artery disease	0.000153	0.00191	CbGeAlD
Sunitinib—YES1—myocardium—coronary artery disease	0.000153	0.00191	CbGeAlD
Sunitinib—DAPK3—cardiac atrium—coronary artery disease	0.000153	0.00191	CbGeAlD
Sunitinib—CLK1—heart—coronary artery disease	0.000152	0.0019	CbGeAlD
Sunitinib—CSNK2A1—blood—coronary artery disease	0.000151	0.0019	CbGeAlD
Sunitinib—CLK2—cardiac atrium—coronary artery disease	0.000151	0.00189	CbGeAlD
Sunitinib—MAP4K4—cardiovascular system—coronary artery disease	0.000151	0.00189	CbGeAlD
Sunitinib—TAOK3—myocardium—coronary artery disease	0.000151	0.00189	CbGeAlD
Sunitinib—MYLK—blood—coronary artery disease	0.000149	0.00187	CbGeAlD
Sunitinib—FLT3—cardiovascular system—coronary artery disease	0.000149	0.00187	CbGeAlD
Sunitinib—BMP2K—heart—coronary artery disease	0.000149	0.00187	CbGeAlD
Sunitinib—CAMK2G—heart—coronary artery disease	0.000149	0.00187	CbGeAlD
Sunitinib—LRRK2—heart—coronary artery disease	0.000148	0.00185	CbGeAlD
Sunitinib—PLK4—blood—coronary artery disease	0.000148	0.00185	CbGeAlD
Sunitinib—RPS6KA3—cardiovascular system—coronary artery disease	0.000147	0.00184	CbGeAlD
Sunitinib—STK4—blood—coronary artery disease	0.000147	0.00184	CbGeAlD
Sunitinib—MAP2K1—cardiovascular system—coronary artery disease	0.000146	0.00183	CbGeAlD
Sunitinib—PRKAA1—heart—coronary artery disease	0.000146	0.00182	CbGeAlD
Sunitinib—CSNK1A1—cardiovascular system—coronary artery disease	0.000144	0.0018	CbGeAlD
Sunitinib—PTK2B—heart—coronary artery disease	0.000144	0.0018	CbGeAlD
Sunitinib—KDR—cardiac ventricle—coronary artery disease	0.000144	0.0018	CbGeAlD
Sunitinib—FLT4—heart—coronary artery disease	0.000143	0.0018	CbGeAlD
Sunitinib—STK24—blood—coronary artery disease	0.000143	0.00179	CbGeAlD
Sunitinib—CLK1—cardiovascular system—coronary artery disease	0.000143	0.00179	CbGeAlD
Sunitinib—DAPK2—blood—coronary artery disease	0.000142	0.00177	CbGeAlD
Sunitinib—CSNK1E—heart—coronary artery disease	0.000142	0.00177	CbGeAlD
Sunitinib—FGFR1—heart—coronary artery disease	0.000142	0.00177	CbGeAlD
Sunitinib—PRPF4—Fluvastatin—Atorvastatin—coronary artery disease	0.000141	0.0582	CbGdCrCtD
Sunitinib—CAMK2G—cardiovascular system—coronary artery disease	0.000141	0.00176	CbGeAlD
Sunitinib—STK16—blood—coronary artery disease	0.000139	0.00175	CbGeAlD
Sunitinib—IRAK4—heart—coronary artery disease	0.000139	0.00174	CbGeAlD
Sunitinib—HIPK3—blood—coronary artery disease	0.000139	0.00174	CbGeAlD
Sunitinib—ALK—blood—coronary artery disease	0.000139	0.00174	CbGeAlD
Sunitinib—PRKAA1—cardiovascular system—coronary artery disease	0.000137	0.00172	CbGeAlD
Sunitinib—RIOK2—blood—coronary artery disease	0.000137	0.00172	CbGeAlD
Sunitinib—TNK1—blood—coronary artery disease	0.000137	0.00172	CbGeAlD
Sunitinib—MAP4K4—cardiac atrium—coronary artery disease	0.000137	0.00172	CbGeAlD
Sunitinib—MAP4K4—Testosterone Propionate—Eplerenone—coronary artery disease	0.000137	0.0564	CbGdCrCtD
Sunitinib—ULK3—heart—coronary artery disease	0.000136	0.00171	CbGeAlD
Sunitinib—MAP2K2—heart—coronary artery disease	0.000136	0.00171	CbGeAlD
Sunitinib—MAP4K1—blood—coronary artery disease	0.000136	0.0017	CbGeAlD
Sunitinib—PTK2B—cardiovascular system—coronary artery disease	0.000136	0.0017	CbGeAlD
Sunitinib—FLT4—cardiovascular system—coronary artery disease	0.000135	0.0017	CbGeAlD
Sunitinib—MAP3K2—heart—coronary artery disease	0.000135	0.00169	CbGeAlD
Sunitinib—KDR—myocardium—coronary artery disease	0.000135	0.00169	CbGeAlD
Sunitinib—MAP2K5—myocardium—coronary artery disease	0.000135	0.00169	CbGeAlD
Sunitinib—MAP3K12—cardiac atrium—coronary artery disease	0.000135	0.00169	CbGeAlD
Sunitinib—MAP3K7—heart—coronary artery disease	0.000134	0.00168	CbGeAlD
Sunitinib—RPS6KA3—cardiac atrium—coronary artery disease	0.000133	0.00167	CbGeAlD
Sunitinib—DAPK3—blood—coronary artery disease	0.000133	0.00167	CbGeAlD
Sunitinib—TBK1—heart—coronary artery disease	0.000132	0.00166	CbGeAlD
Sunitinib—CLK2—blood—coronary artery disease	0.000132	0.00165	CbGeAlD
Sunitinib—TYK2—heart—coronary artery disease	0.000132	0.00165	CbGeAlD
Sunitinib—MAP4K2—blood—coronary artery disease	0.000131	0.00164	CbGeAlD
Sunitinib—CSNK1A1—cardiac atrium—coronary artery disease	0.000131	0.00164	CbGeAlD
Sunitinib—IRAK1—heart—coronary artery disease	0.00013	0.00163	CbGeAlD
Sunitinib—CLK1—cardiac atrium—coronary artery disease	0.00013	0.00163	CbGeAlD
Sunitinib—STK3—blood—coronary artery disease	0.00013	0.00162	CbGeAlD
Sunitinib—MAP2K2—cardiovascular system—coronary artery disease	0.000129	0.00161	CbGeAlD
Sunitinib—ROCK1—blood—coronary artery disease	0.000128	0.0016	CbGeAlD
Sunitinib—RPS6KB1—heart—coronary artery disease	0.000127	0.0016	CbGeAlD
Sunitinib—FGR—heart—coronary artery disease	0.000127	0.00159	CbGeAlD
Sunitinib—RET—heart—coronary artery disease	0.000127	0.00159	CbGeAlD
Sunitinib—AXL—heart—coronary artery disease	0.000126	0.00158	CbGeAlD
Sunitinib—TBK1—cardiovascular system—coronary artery disease	0.000125	0.00157	CbGeAlD
Sunitinib—PDGFRB—cardiac ventricle—coronary artery disease	0.000124	0.00156	CbGeAlD
Sunitinib—TYK2—cardiovascular system—coronary artery disease	0.000124	0.00155	CbGeAlD
Sunitinib—MERTK—blood—coronary artery disease	0.000122	0.00153	CbGeAlD
Sunitinib—SLK—heart—coronary artery disease	0.000121	0.00152	CbGeAlD
Sunitinib—FGFR1—cardiac atrium—coronary artery disease	0.000121	0.00152	CbGeAlD
Sunitinib—RPS6KB1—cardiovascular system—coronary artery disease	0.00012	0.00151	CbGeAlD
Sunitinib—KIT—myocardium—coronary artery disease	0.00012	0.0015	CbGeAlD
Sunitinib—JAK2—heart—coronary artery disease	0.00012	0.0015	CbGeAlD
Sunitinib—MAP4K4—blood—coronary artery disease	0.00012	0.0015	CbGeAlD
Sunitinib—FGR—cardiovascular system—coronary artery disease	0.00012	0.0015	CbGeAlD
Sunitinib—AXL—cardiovascular system—coronary artery disease	0.000119	0.00149	CbGeAlD
Sunitinib—NUAK2—blood—coronary artery disease	0.000119	0.00149	CbGeAlD
Sunitinib—FYN—heart—coronary artery disease	0.000118	0.00148	CbGeAlD
Sunitinib—MAP3K12—blood—coronary artery disease	0.000118	0.00148	CbGeAlD
Sunitinib—FLT3—blood—coronary artery disease	0.000118	0.00148	CbGeAlD
Sunitinib—PDGFRB—myocardium—coronary artery disease	0.000117	0.00146	CbGeAlD
Sunitinib—MAP2K2—cardiac atrium—coronary artery disease	0.000117	0.00146	CbGeAlD
Sunitinib—ULK3—cardiac atrium—coronary artery disease	0.000117	0.00146	CbGeAlD
Sunitinib—RPS6KA3—blood—coronary artery disease	0.000116	0.00146	CbGeAlD
Sunitinib—MAP2K1—blood—coronary artery disease	0.000115	0.00145	CbGeAlD
Sunitinib—MAP3K3—heart—coronary artery disease	0.000115	0.00144	CbGeAlD
Sunitinib—MAP4K5—heart—coronary artery disease	0.000115	0.00144	CbGeAlD
Sunitinib—MAP3K7—cardiac atrium—coronary artery disease	0.000115	0.00144	CbGeAlD
Sunitinib—CSNK1A1—blood—coronary artery disease	0.000114	0.00143	CbGeAlD
Sunitinib—FGFR2—cardiovascular system—coronary artery disease	0.000114	0.00142	CbGeAlD
Sunitinib—TBK1—cardiac atrium—coronary artery disease	0.000113	0.00142	CbGeAlD
Sunitinib—CLK1—blood—coronary artery disease	0.000113	0.00142	CbGeAlD
Sunitinib—JAK2—cardiovascular system—coronary artery disease	0.000113	0.00141	CbGeAlD
Sunitinib—TYK2—cardiac atrium—coronary artery disease	0.000113	0.00141	CbGeAlD
Sunitinib—FLT1—heart—coronary artery disease	0.000112	0.0014	CbGeAlD
Sunitinib—FYN—cardiovascular system—coronary artery disease	0.000111	0.0014	CbGeAlD
Sunitinib—CAMK2G—blood—coronary artery disease	0.000111	0.00139	CbGeAlD
Sunitinib—BMP2K—blood—coronary artery disease	0.000111	0.00139	CbGeAlD
Sunitinib—EPHB6—heart—coronary artery disease	0.00011	0.00138	CbGeAlD
Sunitinib—LRRK2—blood—coronary artery disease	0.00011	0.00138	CbGeAlD
Sunitinib—RPS6KB1—cardiac atrium—coronary artery disease	0.000109	0.00136	CbGeAlD
Sunitinib—MAP3K3—cardiovascular system—coronary artery disease	0.000109	0.00136	CbGeAlD
Sunitinib—PRKAA1—blood—coronary artery disease	0.000109	0.00136	CbGeAlD
Sunitinib—AXL—cardiac atrium—coronary artery disease	0.000108	0.00135	CbGeAlD
Sunitinib—PTK2B—blood—coronary artery disease	0.000107	0.00134	CbGeAlD
Sunitinib—FLT4—blood—coronary artery disease	0.000107	0.00134	CbGeAlD
Sunitinib—YES1—heart—coronary artery disease	0.000107	0.00133	CbGeAlD
Sunitinib—CSNK1E—blood—coronary artery disease	0.000106	0.00132	CbGeAlD
Sunitinib—STK10—heart—coronary artery disease	0.000106	0.00132	CbGeAlD
Sunitinib—FLT1—cardiovascular system—coronary artery disease	0.000105	0.00132	CbGeAlD
Sunitinib—TAOK3—heart—coronary artery disease	0.000105	0.00132	CbGeAlD
Sunitinib—PDGFRA—heart—coronary artery disease	0.000105	0.00131	CbGeAlD
Sunitinib—IRAK4—blood—coronary artery disease	0.000104	0.0013	CbGeAlD
Sunitinib—SLK—cardiac atrium—coronary artery disease	0.000104	0.0013	CbGeAlD
Sunitinib—JAK2—cardiac atrium—coronary artery disease	0.000102	0.00128	CbGeAlD
Sunitinib—MAP2K2—blood—coronary artery disease	0.000102	0.00127	CbGeAlD
Sunitinib—ULK3—blood—coronary artery disease	0.000102	0.00127	CbGeAlD
Sunitinib—FYN—cardiac atrium—coronary artery disease	0.000101	0.00126	CbGeAlD
Sunitinib—MAP3K2—blood—coronary artery disease	0.000101	0.00126	CbGeAlD
Sunitinib—MAP3K7—blood—coronary artery disease	0.0001	0.00125	CbGeAlD
Sunitinib—STK10—cardiovascular system—coronary artery disease	9.97e-05	0.00125	CbGeAlD
Sunitinib—TAOK3—cardiovascular system—coronary artery disease	9.93e-05	0.00124	CbGeAlD
Sunitinib—TBK1—blood—coronary artery disease	9.89e-05	0.00124	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—coronary artery disease	9.87e-05	0.00124	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—coronary artery disease	9.87e-05	0.00124	CbGeAlD
Sunitinib—PDGFRA—cardiovascular system—coronary artery disease	9.86e-05	0.00124	CbGeAlD
Sunitinib—TYK2—blood—coronary artery disease	9.82e-05	0.00123	CbGeAlD
Sunitinib—IRAK1—blood—coronary artery disease	9.69e-05	0.00121	CbGeAlD
Sunitinib—FLT1—cardiac atrium—coronary artery disease	9.54e-05	0.00119	CbGeAlD
Sunitinib—RPS6KB1—blood—coronary artery disease	9.51e-05	0.00119	CbGeAlD
Sunitinib—RET—blood—coronary artery disease	9.45e-05	0.00118	CbGeAlD
Sunitinib—FGR—blood—coronary artery disease	9.45e-05	0.00118	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—coronary artery disease	9.43e-05	0.00118	CbGeAlD
Sunitinib—MAP2K5—heart—coronary artery disease	9.43e-05	0.00118	CbGeAlD
Sunitinib—KDR—heart—coronary artery disease	9.43e-05	0.00118	CbGeAlD
Sunitinib—CHEK2—Pitavastatin—Rosuvastatin—coronary artery disease	9.42e-05	0.0389	CbGdCrCtD
Sunitinib—CSF1R—heart—coronary artery disease	9.2e-05	0.00115	CbGeAlD
Sunitinib—YES1—cardiac atrium—coronary artery disease	9.11e-05	0.00114	CbGeAlD
Sunitinib—SLK—blood—coronary artery disease	9.06e-05	0.00113	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—coronary artery disease	9e-05	0.00113	CbGeAlD
Sunitinib—FGFR2—blood—coronary artery disease	8.98e-05	0.00112	CbGeAlD
Sunitinib—JAK2—blood—coronary artery disease	8.93e-05	0.00112	CbGeAlD
Sunitinib—KDR—cardiovascular system—coronary artery disease	8.9e-05	0.00111	CbGeAlD
Sunitinib—MAP2K5—cardiovascular system—coronary artery disease	8.9e-05	0.00111	CbGeAlD
Sunitinib—FYN—blood—coronary artery disease	8.81e-05	0.0011	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—coronary artery disease	8.68e-05	0.00109	CbGeAlD
Sunitinib—MAP4K5—blood—coronary artery disease	8.61e-05	0.00108	CbGeAlD
Sunitinib—MAP3K3—blood—coronary artery disease	8.61e-05	0.00108	CbGeAlD
Sunitinib—KIT—heart—coronary artery disease	8.36e-05	0.00105	CbGeAlD
Sunitinib—FLT1—blood—coronary artery disease	8.33e-05	0.00104	CbGeAlD
Sunitinib—EPHB6—blood—coronary artery disease	8.23e-05	0.00103	CbGeAlD
Sunitinib—PDGFRB—heart—coronary artery disease	8.16e-05	0.00102	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—coronary artery disease	8.07e-05	0.00101	CbGeAlD
Sunitinib—KDR—cardiac atrium—coronary artery disease	8.07e-05	0.00101	CbGeAlD
Sunitinib—CHEK2—Pitavastatin—Atorvastatin—coronary artery disease	8.01e-05	0.0331	CbGdCrCtD
Sunitinib—YES1—blood—coronary artery disease	7.95e-05	0.000996	CbGeAlD
Sunitinib—KIT—cardiovascular system—coronary artery disease	7.89e-05	0.000987	CbGeAlD
Sunitinib—STK10—blood—coronary artery disease	7.88e-05	0.000987	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—coronary artery disease	7.87e-05	0.000986	CbGeAlD
Sunitinib—KCNH2—cardiac ventricle—coronary artery disease	7.86e-05	0.000984	CbGeAlD
Sunitinib—TAOK3—blood—coronary artery disease	7.85e-05	0.000983	CbGeAlD
Sunitinib—PDGFRA—blood—coronary artery disease	7.8e-05	0.000977	CbGeAlD
Sunitinib—PDGFRB—cardiovascular system—coronary artery disease	7.7e-05	0.000964	CbGeAlD
Sunitinib—KCNH2—myocardium—coronary artery disease	7.39e-05	0.000925	CbGeAlD
Sunitinib—KDR—blood—coronary artery disease	7.04e-05	0.000881	CbGeAlD
Sunitinib—MAP2K5—blood—coronary artery disease	7.04e-05	0.000881	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—coronary artery disease	6.98e-05	0.000874	CbGeAlD
Sunitinib—CSF1R—blood—coronary artery disease	6.87e-05	0.00086	CbGeAlD
Sunitinib—ABCC4—heart—coronary artery disease	6.5e-05	0.000814	CbGeAlD
Sunitinib—KIT—blood—coronary artery disease	6.24e-05	0.000781	CbGeAlD
Sunitinib—PDGFRB—blood—coronary artery disease	6.09e-05	0.000763	CbGeAlD
Sunitinib—KCNH2—heart—coronary artery disease	5.16e-05	0.000646	CbGeAlD
Sunitinib—KCNH2—cardiovascular system—coronary artery disease	4.87e-05	0.000609	CbGeAlD
Sunitinib—ABCC4—blood—coronary artery disease	4.85e-05	0.000607	CbGeAlD
Sunitinib—ABCC2—blood—coronary artery disease	4.69e-05	0.000588	CbGeAlD
Sunitinib—ABCG2—heart—coronary artery disease	4.59e-05	0.000574	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—coronary artery disease	4.41e-05	0.000552	CbGeAlD
Sunitinib—KCNH2—blood—coronary artery disease	3.85e-05	0.000482	CbGeAlD
Sunitinib—CHEK2—Testosterone Propionate—Eplerenone—coronary artery disease	3.83e-05	0.0158	CbGdCrCtD
Sunitinib—ABCG2—blood—coronary artery disease	3.42e-05	0.000429	CbGeAlD
Sunitinib—CYP3A5—blood—coronary artery disease	3.18e-05	0.000398	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Dermatitis—Clopidogrel—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Asthenia—Valsartan—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Hypertension—Timolol—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Pain—Furosemide—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Constipation—Furosemide—coronary artery disease	2.84e-05	0.000219	CcSEcCtD
Sunitinib—Hypersensitivity—Niacin—coronary artery disease	2.84e-05	0.000218	CcSEcCtD
Sunitinib—Asthenia—Olmesartan—coronary artery disease	2.83e-05	0.000218	CcSEcCtD
Sunitinib—Headache—Clopidogrel—coronary artery disease	2.83e-05	0.000218	CcSEcCtD
Sunitinib—Rash—Lovastatin—coronary artery disease	2.83e-05	0.000218	CcSEcCtD
Sunitinib—Dermatitis—Lovastatin—coronary artery disease	2.82e-05	0.000218	CcSEcCtD
Sunitinib—Anaemia—Lisinopril—coronary artery disease	2.82e-05	0.000217	CcSEcCtD
Sunitinib—Dyspepsia—Losartan—coronary artery disease	2.82e-05	0.000217	CcSEcCtD
Sunitinib—Headache—Lovastatin—coronary artery disease	2.81e-05	0.000216	CcSEcCtD
Sunitinib—Pruritus—Valsartan—coronary artery disease	2.8e-05	0.000216	CcSEcCtD
Sunitinib—Dry mouth—Ramipril—coronary artery disease	2.8e-05	0.000216	CcSEcCtD
Sunitinib—Chest pain—Timolol—coronary artery disease	2.8e-05	0.000216	CcSEcCtD
Sunitinib—Myalgia—Timolol—coronary artery disease	2.8e-05	0.000216	CcSEcCtD
Sunitinib—Arthralgia—Timolol—coronary artery disease	2.8e-05	0.000216	CcSEcCtD
Sunitinib—Vomiting—Ezetimibe—coronary artery disease	2.79e-05	0.000215	CcSEcCtD
Sunitinib—Hypersensitivity—Pravastatin—coronary artery disease	2.79e-05	0.000215	CcSEcCtD
Sunitinib—Gastrointestinal pain—Perindopril—coronary artery disease	2.79e-05	0.000215	CcSEcCtD
Sunitinib—Angioedema—Lisinopril—coronary artery disease	2.79e-05	0.000215	CcSEcCtD
Sunitinib—Pruritus—Olmesartan—coronary artery disease	2.79e-05	0.000215	CcSEcCtD
Sunitinib—Decreased appetite—Losartan—coronary artery disease	2.78e-05	0.000214	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.78e-05	0.000214	CcSEcCtD
Sunitinib—Body temperature increased—Captopril—coronary artery disease	2.78e-05	0.000214	CcSEcCtD
Sunitinib—Abdominal pain—Captopril—coronary artery disease	2.78e-05	0.000214	CcSEcCtD
Sunitinib—Dizziness—Simvastatin—coronary artery disease	2.77e-05	0.000214	CcSEcCtD
Sunitinib—Rash—Ezetimibe—coronary artery disease	2.77e-05	0.000214	CcSEcCtD
Sunitinib—Dermatitis—Ezetimibe—coronary artery disease	2.77e-05	0.000213	CcSEcCtD
Sunitinib—Asthenia—Niacin—coronary artery disease	2.76e-05	0.000213	CcSEcCtD
Sunitinib—Fatigue—Losartan—coronary artery disease	2.76e-05	0.000213	CcSEcCtD
Sunitinib—Headache—Ezetimibe—coronary artery disease	2.75e-05	0.000212	CcSEcCtD
Sunitinib—Oedema—Ramipril—coronary artery disease	2.74e-05	0.000212	CcSEcCtD
Sunitinib—Dry mouth—Timolol—coronary artery disease	2.74e-05	0.000211	CcSEcCtD
Sunitinib—Pain—Losartan—coronary artery disease	2.74e-05	0.000211	CcSEcCtD
Sunitinib—Constipation—Losartan—coronary artery disease	2.74e-05	0.000211	CcSEcCtD
Sunitinib—Vomiting—Eplerenone—coronary artery disease	2.74e-05	0.000211	CcSEcCtD
Sunitinib—Leukopenia—Lisinopril—coronary artery disease	2.73e-05	0.00021	CcSEcCtD
Sunitinib—Nausea—Fenofibrate—coronary artery disease	2.73e-05	0.00021	CcSEcCtD
Sunitinib—Pruritus—Niacin—coronary artery disease	2.72e-05	0.00021	CcSEcCtD
Sunitinib—Asthenia—Pravastatin—coronary artery disease	2.72e-05	0.000209	CcSEcCtD
Sunitinib—Gastrointestinal pain—Furosemide—coronary artery disease	2.71e-05	0.000209	CcSEcCtD
Sunitinib—Rash—Eplerenone—coronary artery disease	2.71e-05	0.000209	CcSEcCtD
Sunitinib—Hypersensitivity—Trandolapril—coronary artery disease	2.71e-05	0.000209	CcSEcCtD
Sunitinib—Dermatitis—Eplerenone—coronary artery disease	2.71e-05	0.000209	CcSEcCtD
Sunitinib—Diarrhoea—Valsartan—coronary artery disease	2.71e-05	0.000209	CcSEcCtD
Sunitinib—Shock—Ramipril—coronary artery disease	2.7e-05	0.000208	CcSEcCtD
Sunitinib—Hypersensitivity—Enalapril—coronary artery disease	2.7e-05	0.000208	CcSEcCtD
Sunitinib—Body temperature increased—Perindopril—coronary artery disease	2.7e-05	0.000208	CcSEcCtD
Sunitinib—Abdominal pain—Perindopril—coronary artery disease	2.7e-05	0.000208	CcSEcCtD
Sunitinib—Diarrhoea—Olmesartan—coronary artery disease	2.7e-05	0.000208	CcSEcCtD
Sunitinib—Headache—Eplerenone—coronary artery disease	2.69e-05	0.000208	CcSEcCtD
Sunitinib—Nervous system disorder—Ramipril—coronary artery disease	2.69e-05	0.000207	CcSEcCtD
Sunitinib—Thrombocytopenia—Ramipril—coronary artery disease	2.69e-05	0.000207	CcSEcCtD
Sunitinib—Oedema—Timolol—coronary artery disease	2.68e-05	0.000207	CcSEcCtD
Sunitinib—Pruritus—Pravastatin—coronary artery disease	2.68e-05	0.000207	CcSEcCtD
Sunitinib—Nausea—Clopidogrel—coronary artery disease	2.68e-05	0.000206	CcSEcCtD
Sunitinib—Skin disorder—Ramipril—coronary artery disease	2.67e-05	0.000205	CcSEcCtD
Sunitinib—Infection—Timolol—coronary artery disease	2.67e-05	0.000205	CcSEcCtD
Sunitinib—Vomiting—Simvastatin—coronary artery disease	2.66e-05	0.000205	CcSEcCtD
Sunitinib—Hypersensitivity—Telmisartan—coronary artery disease	2.66e-05	0.000205	CcSEcCtD
Sunitinib—Cough—Lisinopril—coronary artery disease	2.66e-05	0.000205	CcSEcCtD
Sunitinib—Nausea—Lovastatin—coronary artery disease	2.66e-05	0.000205	CcSEcCtD
Sunitinib—Rash—Simvastatin—coronary artery disease	2.64e-05	0.000204	CcSEcCtD
Sunitinib—Dermatitis—Simvastatin—coronary artery disease	2.64e-05	0.000203	CcSEcCtD
Sunitinib—Asthenia—Trandolapril—coronary artery disease	2.64e-05	0.000203	CcSEcCtD
Sunitinib—Shock—Timolol—coronary artery disease	2.64e-05	0.000203	CcSEcCtD
Sunitinib—Diarrhoea—Niacin—coronary artery disease	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Nervous system disorder—Timolol—coronary artery disease	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Asthenia—Enalapril—coronary artery disease	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Headache—Simvastatin—coronary artery disease	2.63e-05	0.000202	CcSEcCtD
Sunitinib—Body temperature increased—Furosemide—coronary artery disease	2.62e-05	0.000202	CcSEcCtD
Sunitinib—Abdominal pain—Furosemide—coronary artery disease	2.62e-05	0.000202	CcSEcCtD
Sunitinib—Gastrointestinal pain—Losartan—coronary artery disease	2.62e-05	0.000202	CcSEcCtD
Sunitinib—Dizziness—Valsartan—coronary artery disease	2.62e-05	0.000202	CcSEcCtD
Sunitinib—Anorexia—Ramipril—coronary artery disease	2.62e-05	0.000202	CcSEcCtD
Sunitinib—Nausea—Ezetimibe—coronary artery disease	2.61e-05	0.000201	CcSEcCtD
Sunitinib—Skin disorder—Timolol—coronary artery disease	2.61e-05	0.000201	CcSEcCtD
Sunitinib—Dizziness—Olmesartan—coronary artery disease	2.6e-05	0.000201	CcSEcCtD
Sunitinib—Pruritus—Trandolapril—coronary artery disease	2.6e-05	0.000201	CcSEcCtD
Sunitinib—Chest pain—Lisinopril—coronary artery disease	2.6e-05	0.0002	CcSEcCtD
Sunitinib—Arthralgia—Lisinopril—coronary artery disease	2.6e-05	0.0002	CcSEcCtD
Sunitinib—Myalgia—Lisinopril—coronary artery disease	2.6e-05	0.0002	CcSEcCtD
Sunitinib—Asthenia—Telmisartan—coronary artery disease	2.59e-05	0.0002	CcSEcCtD
Sunitinib—Pruritus—Enalapril—coronary artery disease	2.59e-05	0.0002	CcSEcCtD
Sunitinib—Diarrhoea—Pravastatin—coronary artery disease	2.59e-05	0.0002	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.58e-05	0.000199	CcSEcCtD
Sunitinib—Anorexia—Timolol—coronary artery disease	2.56e-05	0.000197	CcSEcCtD
Sunitinib—Pruritus—Telmisartan—coronary artery disease	2.56e-05	0.000197	CcSEcCtD
Sunitinib—Nausea—Eplerenone—coronary artery disease	2.56e-05	0.000197	CcSEcCtD
Sunitinib—Dizziness—Niacin—coronary artery disease	2.55e-05	0.000196	CcSEcCtD
Sunitinib—Dry mouth—Lisinopril—coronary artery disease	2.54e-05	0.000196	CcSEcCtD
Sunitinib—Abdominal pain—Losartan—coronary artery disease	2.53e-05	0.000195	CcSEcCtD
Sunitinib—Body temperature increased—Losartan—coronary artery disease	2.53e-05	0.000195	CcSEcCtD
Sunitinib—Asthenia—Captopril—coronary artery disease	2.52e-05	0.000194	CcSEcCtD
Sunitinib—Diarrhoea—Trandolapril—coronary artery disease	2.52e-05	0.000194	CcSEcCtD
Sunitinib—Vomiting—Valsartan—coronary artery disease	2.52e-05	0.000194	CcSEcCtD
Sunitinib—Diarrhoea—Enalapril—coronary artery disease	2.51e-05	0.000193	CcSEcCtD
Sunitinib—Dizziness—Pravastatin—coronary artery disease	2.51e-05	0.000193	CcSEcCtD
Sunitinib—Vomiting—Olmesartan—coronary artery disease	2.5e-05	0.000193	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.5e-05	0.000193	CcSEcCtD
Sunitinib—Rash—Valsartan—coronary artery disease	2.5e-05	0.000192	CcSEcCtD
Sunitinib—Dermatitis—Valsartan—coronary artery disease	2.49e-05	0.000192	CcSEcCtD
Sunitinib—Nausea—Simvastatin—coronary artery disease	2.49e-05	0.000192	CcSEcCtD
Sunitinib—Oedema—Lisinopril—coronary artery disease	2.49e-05	0.000192	CcSEcCtD
Sunitinib—Pruritus—Captopril—coronary artery disease	2.49e-05	0.000192	CcSEcCtD
Sunitinib—Rash—Olmesartan—coronary artery disease	2.48e-05	0.000191	CcSEcCtD
Sunitinib—Insomnia—Ramipril—coronary artery disease	2.48e-05	0.000191	CcSEcCtD
Sunitinib—Dermatitis—Olmesartan—coronary artery disease	2.48e-05	0.000191	CcSEcCtD
Sunitinib—Headache—Valsartan—coronary artery disease	2.48e-05	0.000191	CcSEcCtD
Sunitinib—Diarrhoea—Telmisartan—coronary artery disease	2.47e-05	0.000191	CcSEcCtD
Sunitinib—Infection—Lisinopril—coronary artery disease	2.47e-05	0.000191	CcSEcCtD
Sunitinib—Headache—Olmesartan—coronary artery disease	2.47e-05	0.00019	CcSEcCtD
Sunitinib—Paraesthesia—Ramipril—coronary artery disease	2.46e-05	0.00019	CcSEcCtD
Sunitinib—Shock—Lisinopril—coronary artery disease	2.45e-05	0.000189	CcSEcCtD
Sunitinib—Asthenia—Perindopril—coronary artery disease	2.45e-05	0.000189	CcSEcCtD
Sunitinib—Dyspnoea—Ramipril—coronary artery disease	2.45e-05	0.000189	CcSEcCtD
Sunitinib—Vomiting—Niacin—coronary artery disease	2.45e-05	0.000189	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Timolol—coronary artery disease	2.44e-05	0.000188	CcSEcCtD
Sunitinib—Hypersensitivity—Furosemide—coronary artery disease	2.44e-05	0.000188	CcSEcCtD
Sunitinib—Thrombocytopenia—Lisinopril—coronary artery disease	2.44e-05	0.000188	CcSEcCtD
Sunitinib—Dizziness—Trandolapril—coronary artery disease	2.43e-05	0.000188	CcSEcCtD
Sunitinib—Insomnia—Timolol—coronary artery disease	2.43e-05	0.000187	CcSEcCtD
Sunitinib—Rash—Niacin—coronary artery disease	2.43e-05	0.000187	CcSEcCtD
Sunitinib—Dermatitis—Niacin—coronary artery disease	2.42e-05	0.000187	CcSEcCtD
Sunitinib—Dizziness—Enalapril—coronary artery disease	2.42e-05	0.000187	CcSEcCtD
Sunitinib—Skin disorder—Lisinopril—coronary artery disease	2.42e-05	0.000186	CcSEcCtD
Sunitinib—Dyspepsia—Ramipril—coronary artery disease	2.42e-05	0.000186	CcSEcCtD
Sunitinib—Pruritus—Perindopril—coronary artery disease	2.41e-05	0.000186	CcSEcCtD
Sunitinib—Headache—Niacin—coronary artery disease	2.41e-05	0.000186	CcSEcCtD
Sunitinib—Paraesthesia—Timolol—coronary artery disease	2.41e-05	0.000186	CcSEcCtD
Sunitinib—Vomiting—Pravastatin—coronary artery disease	2.41e-05	0.000186	CcSEcCtD
Sunitinib—Diarrhoea—Captopril—coronary artery disease	2.41e-05	0.000185	CcSEcCtD
Sunitinib—Dyspnoea—Timolol—coronary artery disease	2.39e-05	0.000184	CcSEcCtD
Sunitinib—Dizziness—Telmisartan—coronary artery disease	2.39e-05	0.000184	CcSEcCtD
Sunitinib—Rash—Pravastatin—coronary artery disease	2.39e-05	0.000184	CcSEcCtD
Sunitinib—Dermatitis—Pravastatin—coronary artery disease	2.39e-05	0.000184	CcSEcCtD
Sunitinib—Decreased appetite—Ramipril—coronary artery disease	2.39e-05	0.000184	CcSEcCtD
Sunitinib—CYP3A4—blood—coronary artery disease	2.39e-05	0.000299	CbGeAlD
Sunitinib—Asthenia—Furosemide—coronary artery disease	2.38e-05	0.000183	CcSEcCtD
Sunitinib—Headache—Pravastatin—coronary artery disease	2.37e-05	0.000183	CcSEcCtD
Sunitinib—Anorexia—Lisinopril—coronary artery disease	2.37e-05	0.000183	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Ramipril—coronary artery disease	2.37e-05	0.000183	CcSEcCtD
Sunitinib—Fatigue—Ramipril—coronary artery disease	2.37e-05	0.000182	CcSEcCtD
Sunitinib—Dyspepsia—Timolol—coronary artery disease	2.36e-05	0.000182	CcSEcCtD
Sunitinib—Hypersensitivity—Losartan—coronary artery disease	2.36e-05	0.000182	CcSEcCtD
Sunitinib—Nausea—Valsartan—coronary artery disease	2.35e-05	0.000181	CcSEcCtD
Sunitinib—Pruritus—Furosemide—coronary artery disease	2.35e-05	0.000181	CcSEcCtD
Sunitinib—Constipation—Ramipril—coronary artery disease	2.35e-05	0.000181	CcSEcCtD
Sunitinib—Nausea—Olmesartan—coronary artery disease	2.34e-05	0.00018	CcSEcCtD
Sunitinib—Vomiting—Trandolapril—coronary artery disease	2.34e-05	0.00018	CcSEcCtD
Sunitinib—Diarrhoea—Perindopril—coronary artery disease	2.34e-05	0.00018	CcSEcCtD
Sunitinib—Decreased appetite—Timolol—coronary artery disease	2.33e-05	0.00018	CcSEcCtD
Sunitinib—Vomiting—Enalapril—coronary artery disease	2.33e-05	0.00018	CcSEcCtD
Sunitinib—Dizziness—Captopril—coronary artery disease	2.32e-05	0.000179	CcSEcCtD
Sunitinib—Rash—Trandolapril—coronary artery disease	2.32e-05	0.000179	CcSEcCtD
Sunitinib—Dermatitis—Trandolapril—coronary artery disease	2.32e-05	0.000179	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Timolol—coronary artery disease	2.32e-05	0.000179	CcSEcCtD
Sunitinib—Fatigue—Timolol—coronary artery disease	2.31e-05	0.000178	CcSEcCtD
Sunitinib—Rash—Enalapril—coronary artery disease	2.31e-05	0.000178	CcSEcCtD
Sunitinib—Dermatitis—Enalapril—coronary artery disease	2.31e-05	0.000178	CcSEcCtD
Sunitinib—Headache—Trandolapril—coronary artery disease	2.31e-05	0.000178	CcSEcCtD
Sunitinib—Vomiting—Telmisartan—coronary artery disease	2.3e-05	0.000177	CcSEcCtD
Sunitinib—Asthenia—Losartan—coronary artery disease	2.3e-05	0.000177	CcSEcCtD
Sunitinib—Headache—Enalapril—coronary artery disease	2.3e-05	0.000177	CcSEcCtD
Sunitinib—Pain—Timolol—coronary artery disease	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Nausea—Niacin—coronary artery disease	2.29e-05	0.000176	CcSEcCtD
Sunitinib—Rash—Telmisartan—coronary artery disease	2.28e-05	0.000176	CcSEcCtD
Sunitinib—Dermatitis—Telmisartan—coronary artery disease	2.28e-05	0.000175	CcSEcCtD
Sunitinib—Diarrhoea—Furosemide—coronary artery disease	2.27e-05	0.000175	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.27e-05	0.000175	CcSEcCtD
Sunitinib—Pruritus—Losartan—coronary artery disease	2.26e-05	0.000175	CcSEcCtD
Sunitinib—Headache—Telmisartan—coronary artery disease	2.26e-05	0.000175	CcSEcCtD
Sunitinib—ABCB1—heart—coronary artery disease	2.26e-05	0.000283	CbGeAlD
Sunitinib—Dizziness—Perindopril—coronary artery disease	2.26e-05	0.000174	CcSEcCtD
Sunitinib—Insomnia—Lisinopril—coronary artery disease	2.25e-05	0.000173	CcSEcCtD
Sunitinib—Nausea—Pravastatin—coronary artery disease	2.25e-05	0.000173	CcSEcCtD
Sunitinib—Gastrointestinal pain—Ramipril—coronary artery disease	2.24e-05	0.000173	CcSEcCtD
Sunitinib—Paraesthesia—Lisinopril—coronary artery disease	2.24e-05	0.000172	CcSEcCtD
Sunitinib—Vomiting—Captopril—coronary artery disease	2.24e-05	0.000172	CcSEcCtD
Sunitinib—Dyspnoea—Lisinopril—coronary artery disease	2.22e-05	0.000171	CcSEcCtD
Sunitinib—Rash—Captopril—coronary artery disease	2.22e-05	0.000171	CcSEcCtD
Sunitinib—Dermatitis—Captopril—coronary artery disease	2.21e-05	0.000171	CcSEcCtD
Sunitinib—Headache—Captopril—coronary artery disease	2.2e-05	0.00017	CcSEcCtD
Sunitinib—Gastrointestinal pain—Timolol—coronary artery disease	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Dizziness—Furosemide—coronary artery disease	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Dyspepsia—Lisinopril—coronary artery disease	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Diarrhoea—Losartan—coronary artery disease	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Nausea—Trandolapril—coronary artery disease	2.19e-05	0.000168	CcSEcCtD
Sunitinib—Nausea—Enalapril—coronary artery disease	2.18e-05	0.000168	CcSEcCtD
Sunitinib—Vomiting—Perindopril—coronary artery disease	2.17e-05	0.000167	CcSEcCtD
Sunitinib—Abdominal pain—Ramipril—coronary artery disease	2.17e-05	0.000167	CcSEcCtD
Sunitinib—Body temperature increased—Ramipril—coronary artery disease	2.17e-05	0.000167	CcSEcCtD
Sunitinib—Decreased appetite—Lisinopril—coronary artery disease	2.16e-05	0.000167	CcSEcCtD
Sunitinib—Rash—Perindopril—coronary artery disease	2.15e-05	0.000166	CcSEcCtD
Sunitinib—Dermatitis—Perindopril—coronary artery disease	2.15e-05	0.000166	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.15e-05	0.000166	CcSEcCtD
Sunitinib—Nausea—Telmisartan—coronary artery disease	2.15e-05	0.000165	CcSEcCtD
Sunitinib—Fatigue—Lisinopril—coronary artery disease	2.15e-05	0.000165	CcSEcCtD
Sunitinib—Headache—Perindopril—coronary artery disease	2.14e-05	0.000165	CcSEcCtD
Sunitinib—ABCB1—cardiovascular system—coronary artery disease	2.13e-05	0.000267	CbGeAlD
Sunitinib—Constipation—Lisinopril—coronary artery disease	2.13e-05	0.000164	CcSEcCtD
Sunitinib—Pain—Lisinopril—coronary artery disease	2.13e-05	0.000164	CcSEcCtD
Sunitinib—Abdominal pain—Timolol—coronary artery disease	2.12e-05	0.000163	CcSEcCtD
Sunitinib—Body temperature increased—Timolol—coronary artery disease	2.12e-05	0.000163	CcSEcCtD
Sunitinib—Dizziness—Losartan—coronary artery disease	2.12e-05	0.000163	CcSEcCtD
Sunitinib—Vomiting—Furosemide—coronary artery disease	2.11e-05	0.000163	CcSEcCtD
Sunitinib—Rash—Furosemide—coronary artery disease	2.09e-05	0.000161	CcSEcCtD
Sunitinib—Dermatitis—Furosemide—coronary artery disease	2.09e-05	0.000161	CcSEcCtD
Sunitinib—Nausea—Captopril—coronary artery disease	2.09e-05	0.000161	CcSEcCtD
Sunitinib—Headache—Furosemide—coronary artery disease	2.08e-05	0.00016	CcSEcCtD
Sunitinib—Gastrointestinal pain—Lisinopril—coronary artery disease	2.04e-05	0.000157	CcSEcCtD
Sunitinib—Vomiting—Losartan—coronary artery disease	2.04e-05	0.000157	CcSEcCtD
Sunitinib—Nausea—Perindopril—coronary artery disease	2.03e-05	0.000156	CcSEcCtD
Sunitinib—Hypersensitivity—Ramipril—coronary artery disease	2.02e-05	0.000156	CcSEcCtD
Sunitinib—Rash—Losartan—coronary artery disease	2.02e-05	0.000156	CcSEcCtD
Sunitinib—Dermatitis—Losartan—coronary artery disease	2.02e-05	0.000155	CcSEcCtD
Sunitinib—Headache—Losartan—coronary artery disease	2.01e-05	0.000155	CcSEcCtD
Sunitinib—Hypersensitivity—Timolol—coronary artery disease	1.98e-05	0.000152	CcSEcCtD
Sunitinib—Nausea—Furosemide—coronary artery disease	1.97e-05	0.000152	CcSEcCtD
Sunitinib—Asthenia—Ramipril—coronary artery disease	1.97e-05	0.000152	CcSEcCtD
Sunitinib—Body temperature increased—Lisinopril—coronary artery disease	1.97e-05	0.000152	CcSEcCtD
Sunitinib—Abdominal pain—Lisinopril—coronary artery disease	1.97e-05	0.000152	CcSEcCtD
Sunitinib—Pruritus—Ramipril—coronary artery disease	1.94e-05	0.00015	CcSEcCtD
Sunitinib—Asthenia—Timolol—coronary artery disease	1.93e-05	0.000148	CcSEcCtD
Sunitinib—Nausea—Losartan—coronary artery disease	1.9e-05	0.000147	CcSEcCtD
Sunitinib—Pruritus—Timolol—coronary artery disease	1.9e-05	0.000146	CcSEcCtD
Sunitinib—Diarrhoea—Ramipril—coronary artery disease	1.88e-05	0.000145	CcSEcCtD
Sunitinib—Diarrhoea—Timolol—coronary artery disease	1.84e-05	0.000141	CcSEcCtD
Sunitinib—Hypersensitivity—Lisinopril—coronary artery disease	1.83e-05	0.000141	CcSEcCtD
Sunitinib—Dizziness—Ramipril—coronary artery disease	1.82e-05	0.00014	CcSEcCtD
Sunitinib—Asthenia—Lisinopril—coronary artery disease	1.79e-05	0.000138	CcSEcCtD
Sunitinib—Dizziness—Timolol—coronary artery disease	1.77e-05	0.000137	CcSEcCtD
Sunitinib—Pruritus—Lisinopril—coronary artery disease	1.76e-05	0.000136	CcSEcCtD
Sunitinib—Vomiting—Ramipril—coronary artery disease	1.75e-05	0.000134	CcSEcCtD
Sunitinib—Rash—Ramipril—coronary artery disease	1.73e-05	0.000133	CcSEcCtD
Sunitinib—Dermatitis—Ramipril—coronary artery disease	1.73e-05	0.000133	CcSEcCtD
Sunitinib—Headache—Ramipril—coronary artery disease	1.72e-05	0.000133	CcSEcCtD
Sunitinib—Vomiting—Timolol—coronary artery disease	1.71e-05	0.000131	CcSEcCtD
Sunitinib—Diarrhoea—Lisinopril—coronary artery disease	1.7e-05	0.000131	CcSEcCtD
Sunitinib—Rash—Timolol—coronary artery disease	1.69e-05	0.00013	CcSEcCtD
Sunitinib—Dermatitis—Timolol—coronary artery disease	1.69e-05	0.00013	CcSEcCtD
Sunitinib—ABCB1—blood—coronary artery disease	1.69e-05	0.000211	CbGeAlD
Sunitinib—Headache—Timolol—coronary artery disease	1.68e-05	0.00013	CcSEcCtD
Sunitinib—Dizziness—Lisinopril—coronary artery disease	1.65e-05	0.000127	CcSEcCtD
Sunitinib—Nausea—Ramipril—coronary artery disease	1.63e-05	0.000126	CcSEcCtD
Sunitinib—Nausea—Timolol—coronary artery disease	1.59e-05	0.000123	CcSEcCtD
Sunitinib—Vomiting—Lisinopril—coronary artery disease	1.58e-05	0.000122	CcSEcCtD
Sunitinib—Rash—Lisinopril—coronary artery disease	1.57e-05	0.000121	CcSEcCtD
Sunitinib—Dermatitis—Lisinopril—coronary artery disease	1.57e-05	0.000121	CcSEcCtD
Sunitinib—Headache—Lisinopril—coronary artery disease	1.56e-05	0.00012	CcSEcCtD
Sunitinib—Nausea—Lisinopril—coronary artery disease	1.48e-05	0.000114	CcSEcCtD
Sunitinib—ABCB1—Metabolism—GSTP1—coronary artery disease	1.72e-07	1.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—coronary artery disease	1.72e-07	1.09e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—coronary artery disease	1.72e-07	1.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—VCAN—coronary artery disease	1.72e-07	1.09e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.71e-07	1.08e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOA1—coronary artery disease	1.71e-07	1.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.71e-07	1.08e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—coronary artery disease	1.7e-07	1.08e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PIK3CA—coronary artery disease	1.7e-07	1.07e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PIK3CA—coronary artery disease	1.7e-07	1.07e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PIK3CA—coronary artery disease	1.7e-07	1.07e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—coronary artery disease	1.69e-07	1.07e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PIK3CA—coronary artery disease	1.69e-07	1.07e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—coronary artery disease	1.69e-07	1.07e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—coronary artery disease	1.69e-07	1.07e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—coronary artery disease	1.68e-07	1.06e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—coronary artery disease	1.68e-07	1.06e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAT—coronary artery disease	1.68e-07	1.06e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—coronary artery disease	1.67e-07	1.06e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—coronary artery disease	1.67e-07	1.06e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—coronary artery disease	1.67e-07	1.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—coronary artery disease	1.67e-07	1.06e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—coronary artery disease	1.66e-07	1.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—coronary artery disease	1.66e-07	1.05e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DCN—coronary artery disease	1.66e-07	1.05e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK1—coronary artery disease	1.65e-07	1.05e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—coronary artery disease	1.65e-07	1.05e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—coronary artery disease	1.65e-07	1.05e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—coronary artery disease	1.65e-07	1.05e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—coronary artery disease	1.65e-07	1.05e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—coronary artery disease	1.65e-07	1.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—coronary artery disease	1.65e-07	1.04e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MAPK1—coronary artery disease	1.65e-07	1.04e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—coronary artery disease	1.65e-07	1.04e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—coronary artery disease	1.65e-07	1.04e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—coronary artery disease	1.64e-07	1.04e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—coronary artery disease	1.64e-07	1.04e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.64e-07	1.04e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—coronary artery disease	1.63e-07	1.03e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—coronary artery disease	1.63e-07	1.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOB—coronary artery disease	1.63e-07	1.03e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—coronary artery disease	1.62e-07	1.03e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—coronary artery disease	1.62e-07	1.03e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—coronary artery disease	1.62e-07	1.03e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—coronary artery disease	1.62e-07	1.03e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—coronary artery disease	1.62e-07	1.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.61e-07	1.02e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—coronary artery disease	1.61e-07	1.02e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—coronary artery disease	1.6e-07	1.01e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—coronary artery disease	1.6e-07	1.01e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—coronary artery disease	1.6e-07	1.01e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—coronary artery disease	1.59e-07	1.01e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—coronary artery disease	1.58e-07	1e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—coronary artery disease	1.58e-07	1e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—coronary artery disease	1.58e-07	1e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—coronary artery disease	1.57e-07	9.95e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HBA1—coronary artery disease	1.57e-07	9.94e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LIPC—coronary artery disease	1.57e-07	9.94e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.57e-07	9.94e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.57e-07	9.94e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK1—coronary artery disease	1.57e-07	9.93e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—coronary artery disease	1.56e-07	9.88e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOC3—coronary artery disease	1.56e-07	9.88e-07	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—coronary artery disease	1.56e-07	9.87e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—coronary artery disease	1.56e-07	9.87e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—coronary artery disease	1.56e-07	9.86e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—coronary artery disease	1.56e-07	9.85e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—coronary artery disease	1.55e-07	9.84e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—coronary artery disease	1.55e-07	9.83e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LDLR—coronary artery disease	1.55e-07	9.82e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—coronary artery disease	1.55e-07	9.81e-07	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—coronary artery disease	1.55e-07	9.81e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—coronary artery disease	1.55e-07	9.81e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—coronary artery disease	1.55e-07	9.8e-07	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—coronary artery disease	1.54e-07	9.76e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—coronary artery disease	1.54e-07	9.75e-07	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—coronary artery disease	1.54e-07	9.74e-07	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—coronary artery disease	1.54e-07	9.73e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—coronary artery disease	1.53e-07	9.72e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—coronary artery disease	1.53e-07	9.72e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—coronary artery disease	1.53e-07	9.71e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—coronary artery disease	1.53e-07	9.71e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.53e-07	9.7e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.53e-07	9.7e-07	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—coronary artery disease	1.53e-07	9.66e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK1—coronary artery disease	1.52e-07	9.64e-07	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—coronary artery disease	1.52e-07	9.64e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—coronary artery disease	1.52e-07	9.61e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCLC—coronary artery disease	1.52e-07	9.59e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CETP—coronary artery disease	1.52e-07	9.59e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—coronary artery disease	1.51e-07	9.57e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—coronary artery disease	1.51e-07	9.54e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—coronary artery disease	1.51e-07	9.54e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—coronary artery disease	1.51e-07	9.53e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—coronary artery disease	1.51e-07	9.53e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK1—coronary artery disease	1.5e-07	9.52e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—coronary artery disease	1.5e-07	9.51e-07	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—coronary artery disease	1.5e-07	9.51e-07	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—coronary artery disease	1.5e-07	9.51e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—coronary artery disease	1.5e-07	9.51e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDC1—coronary artery disease	1.5e-07	9.48e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—coronary artery disease	1.5e-07	9.48e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—coronary artery disease	1.5e-07	9.48e-07	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—coronary artery disease	1.5e-07	9.47e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—coronary artery disease	1.49e-07	9.46e-07	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—coronary artery disease	1.49e-07	9.46e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—coronary artery disease	1.48e-07	9.4e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CD36—coronary artery disease	1.48e-07	9.36e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK1—coronary artery disease	1.48e-07	9.35e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK1—coronary artery disease	1.48e-07	9.35e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—coronary artery disease	1.47e-07	9.31e-07	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—coronary artery disease	1.46e-07	9.27e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.46e-07	9.24e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—coronary artery disease	1.45e-07	9.18e-07	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—coronary artery disease	1.44e-07	9.14e-07	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—coronary artery disease	1.44e-07	9.11e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—coronary artery disease	1.44e-07	9.09e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—coronary artery disease	1.44e-07	9.09e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—coronary artery disease	1.43e-07	9.08e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—coronary artery disease	1.43e-07	9.06e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—coronary artery disease	1.43e-07	9.05e-07	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—coronary artery disease	1.43e-07	9.05e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—coronary artery disease	1.43e-07	9.04e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—coronary artery disease	1.43e-07	9.03e-07	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—coronary artery disease	1.42e-07	8.99e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—coronary artery disease	1.42e-07	8.97e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—coronary artery disease	1.42e-07	8.96e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—coronary artery disease	1.42e-07	8.96e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.42e-07	8.96e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.42e-07	8.96e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK1—coronary artery disease	1.4e-07	8.88e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—coronary artery disease	1.4e-07	8.87e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—coronary artery disease	1.4e-07	8.86e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK1—coronary artery disease	1.4e-07	8.85e-07	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—coronary artery disease	1.39e-07	8.78e-07	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—coronary artery disease	1.39e-07	8.78e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—coronary artery disease	1.39e-07	8.77e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—coronary artery disease	1.38e-07	8.75e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTGF—coronary artery disease	1.38e-07	8.75e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—coronary artery disease	1.38e-07	8.75e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—coronary artery disease	1.37e-07	8.69e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.37e-07	8.67e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT2—coronary artery disease	1.37e-07	8.67e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—coronary artery disease	1.36e-07	8.62e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—coronary artery disease	1.35e-07	8.57e-07	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—coronary artery disease	1.35e-07	8.55e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—coronary artery disease	1.35e-07	8.54e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—coronary artery disease	1.34e-07	8.5e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—coronary artery disease	1.33e-07	8.44e-07	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—coronary artery disease	1.33e-07	8.43e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—coronary artery disease	1.33e-07	8.42e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—coronary artery disease	1.33e-07	8.39e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—coronary artery disease	1.32e-07	8.39e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—coronary artery disease	1.32e-07	8.37e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—coronary artery disease	1.32e-07	8.34e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—coronary artery disease	1.31e-07	8.27e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-07	8.26e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—coronary artery disease	1.3e-07	8.25e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—coronary artery disease	1.29e-07	8.19e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK1—coronary artery disease	1.29e-07	8.17e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—coronary artery disease	1.29e-07	8.16e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—coronary artery disease	1.29e-07	8.13e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—coronary artery disease	1.28e-07	8.12e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—coronary artery disease	1.28e-07	8.12e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—coronary artery disease	1.28e-07	8.12e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—coronary artery disease	1.28e-07	8.08e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—coronary artery disease	1.27e-07	8.05e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—coronary artery disease	1.27e-07	8.02e-07	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—coronary artery disease	1.27e-07	8.01e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK1—coronary artery disease	1.26e-07	7.98e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.26e-07	7.98e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—coronary artery disease	1.24e-07	7.84e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—coronary artery disease	1.23e-07	7.8e-07	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—coronary artery disease	1.23e-07	7.78e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—coronary artery disease	1.22e-07	7.74e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.22e-07	7.73e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—coronary artery disease	1.22e-07	7.7e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK1—coronary artery disease	1.21e-07	7.69e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—coronary artery disease	1.21e-07	7.68e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK1—coronary artery disease	1.21e-07	7.65e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—coronary artery disease	1.21e-07	7.63e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.18e-07	7.49e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GGT1—coronary artery disease	1.18e-07	7.49e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT1—coronary artery disease	1.18e-07	7.49e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—coronary artery disease	1.18e-07	7.45e-07	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—coronary artery disease	1.17e-07	7.43e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—coronary artery disease	1.17e-07	7.41e-07	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—coronary artery disease	1.17e-07	7.4e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—coronary artery disease	1.16e-07	7.32e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK1—coronary artery disease	1.15e-07	7.31e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—coronary artery disease	1.14e-07	7.19e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—coronary artery disease	1.14e-07	7.19e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—coronary artery disease	1.14e-07	7.19e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—coronary artery disease	1.12e-07	7.09e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—coronary artery disease	1.12e-07	7.09e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—coronary artery disease	1.11e-07	7.04e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—coronary artery disease	1.09e-07	6.92e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—coronary artery disease	1.08e-07	6.84e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—coronary artery disease	1.08e-07	6.82e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—coronary artery disease	1.07e-07	6.8e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—coronary artery disease	1.07e-07	6.75e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.06e-07	6.73e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—coronary artery disease	1.05e-07	6.67e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.05e-07	6.66e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—coronary artery disease	1.05e-07	6.64e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.05e-07	6.63e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—coronary artery disease	1.05e-07	6.63e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—coronary artery disease	1.05e-07	6.63e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAT—coronary artery disease	1.03e-07	6.54e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—coronary artery disease	1.02e-07	6.46e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—coronary artery disease	1.02e-07	6.44e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.01e-07	6.38e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOB—coronary artery disease	1e-07	6.35e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—coronary artery disease	1e-07	6.34e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—coronary artery disease	9.94e-08	6.29e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—coronary artery disease	9.92e-08	6.28e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—coronary artery disease	9.92e-08	6.28e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—coronary artery disease	9.77e-08	6.18e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.76e-08	6.18e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—coronary artery disease	9.68e-08	6.13e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—coronary artery disease	9.58e-08	6.07e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—coronary artery disease	9.35e-08	5.92e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—coronary artery disease	9.33e-08	5.91e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—coronary artery disease	9.28e-08	5.88e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—coronary artery disease	9.15e-08	5.79e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD36—coronary artery disease	9.11e-08	5.76e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.99e-08	5.69e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—coronary artery disease	8.93e-08	5.66e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—coronary artery disease	8.93e-08	5.65e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—coronary artery disease	8.87e-08	5.62e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.63e-08	5.46e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—coronary artery disease	8.61e-08	5.45e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—coronary artery disease	8.56e-08	5.42e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—coronary artery disease	8.31e-08	5.26e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—coronary artery disease	8.23e-08	5.21e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—coronary artery disease	8.2e-08	5.19e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—coronary artery disease	8.19e-08	5.18e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—coronary artery disease	8.03e-08	5.09e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—coronary artery disease	7.94e-08	5.03e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—coronary artery disease	7.28e-08	4.61e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—coronary artery disease	7e-08	4.43e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—coronary artery disease	6.9e-08	4.37e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—coronary artery disease	6.29e-08	3.98e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—coronary artery disease	6.02e-08	3.81e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—coronary artery disease	5.95e-08	3.77e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.5e-08	3.48e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.5e-08	3.48e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—coronary artery disease	4.49e-08	2.84e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.39e-08	2.14e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—coronary artery disease	2.77e-08	1.75e-07	CbGpPWpGaD
